Jeff Johnson, Director and New Technology Lead, Global Engineering Solutions, Merck & Co., Inc., delivers a live presentation at INTERPHEX New York on a «Large Scale Single-Use Bulk Drug Substance Freeze and Thaw Platform.» This presentation is an overview of a novel single-use end-to-end solution for freeze, thaw, handling and transport of Bulk Drug Substance. Jeff’s talk touches on design consideration, scalability, stability, and proof of concept.
Catch Jeff Johnson, of Merck & Co., Inc., as he delivers a video presentation on a Large Scale BDS Freeze & Thaw Platform
Jeff Johnson is currently the New Technology Lead and Director, Global Engineering Solutions at Merck & Co., Inc., where he is responsible for the assessment of new manufacturing technology for Merck’s vaccine, biologics, and sterile manufacturing processes. He is also the co-leader of the Process Technology Innovation Community of Practice, and of SUN – Merck’s Single Use Technology initiative. Prior roles include Director of BioProcess Engineering, responsible for business case and concept development for new vaccine and biologics capital projects, and Director of Network Management for Therapeutic Protein Commercialization. Prior to Merck, he worked for Genzyme Corporation, Raytheon Engineers, and ARCO Chemical Co. He holds a BS in Chemical Engineering from the University of Rochester, a MS in Chemical Engineering from the University of Pennsylvania, and a Certificate in Biotechnology from Tufts University.